Navigation Links
Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells

d normally, according to Kurtzberg.

Kurtzberg said their treatment successes provide a strong argument for mandatory, universal screening of all newborns for the genetic lysosomal storage diseases. The major barrier to universal newborn screening is building an infrastructure to support widespread testing, she said. The cost of testing itself would be relatively low.

Although lysosomal storage diseases are rare ?fewer than 5,000 births combined out of 4 million per year in the U.S. ?they are best treated if patients are diagnosed and treated in early infancy, said Kurtzberg. In fact, transplantation in newborns yields the best long-term outcomes and newborns tolerate the transplants more easily than older babies and children.

"Time is of the essence in treating these children before symptoms progress and become irreversible," said Kurtzberg, director of Duke's Pediatric Blood and Marrow Transplant Program. "Delaying the transplant even a week or two can make a noticeable difference in a child's motor skills, so timely diagnosis and treatment is essential to preserving brain and motor function."

Children transplanted after onset of symptoms do stabilize but exhibit minimal neurologic improvement, said Maria Luisa Escolar, MD, of UNC-CH, whose team assessed the neurological, cognitive and physical development of each child with Krabbe Disease before and after transplant.

Escolar is lead author of the study and directs the Program for Neurodevelopmental Function in Rare Disorders at the Center for Development and Learning, UNC-CH. The program is dedicated to tracking the natural history and the effects of new therapies in children with rare diseases.

In the new study, eleven asymptomatic newborns (ages 12 to 44 days) and 14 symptomatic infants (ages 142 days to a year) were treated with unrelated donor umbilical cord blood. Cells from the donor "engrafted" or took hold in all of the patients. All of the asymptomatic newbo
'"/>

Source:DukeHealth


Page: 1 2 3 4

Related biology news :

1. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
2. Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants
3. Infants can organise visual information at just four months
4. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
5. Genetically modified natural killer immune cells attack, kill leukemia cells
6. Ants Genetic Engineering Leads To Species Interdependency
7. Genetic Variation Visualization - From EMBL
8. Genetically modified rice in China benefits farmers health, study finds
9. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
10. Genetic defects give the immune system the green light to attack the pancreas
11. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
Post Your Comments:
Breaking Biology News(10 mins):University of Washington professor garners Avanti Young Investigator Award 2Vermicompost from pig manure grows healthy hibiscus 2'Fighting' IED attacks with SCARE technology 2'Fighting' IED attacks with SCARE technology 3The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 1The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 2The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 3The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 4Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 1Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 2Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 3deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 1deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 2deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 3
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4